Summary
40 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $143.3M against $100.8M.
- Out of every 100 USD of revenue, 10.0 USD is left as free cash.
- Analysts expect revenue to grow by 12% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 7.8% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 8.0% a year over 5 years. Over the last 3 years it fell by 7.8% a year. For the next fiscal year analysts expect revenue to grow by 12%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $111.2M.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 14
- Hold 13
- Sell 1
Today's price within the analysts' price targets
The average target of $6.68 is 14% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- UNITED STATES 82%
- SPAIN 11%
- BRAZIL 4.8%
- AUSTRALIA 1.9%
UNITED STATES brings in 82% of revenue. AUSTRALIA grew fastest, by 44% a year.
Segments in detail